Treatment intensification with insulin degludec improves glycaemic control in patients with Type 2 diabetes treated with liraglutide and metformin

被引：0
|
作者：
Kumar, S. [1 ]
Aroda, V. [2 ]
Bailey, T. [3 ]
Cariou, B. [4 ]
Leiter, L. [5 ]
Raskin, P. [6 ]
Zacho, J. [7 ]
Philis-Tsimikas, A. [8 ]
机构：
[1] Univ Hosp Coventry & Warwickshire, WISDEM Ctr, Coventry, W Midlands, England
[2] MedStar Hlth Res Inst, Endocrinol Diabet & Metab, Hyattsville, MD USA
[3] AMCR Inst, Escondido, CA USA
[4] Univ Nantes, Dept Endocrinol, Nantes, France
[5] Univ Toronto, St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON, Canada
[6] Univ Texas SW Med Ctr Dallas, Div Endocrinol, Internal Med, Dallas, TX 75390 USA
[7] Novo Nordisk AS, Soborg, Denmark
[8] Scripps Whittier Diabet Inst, San Diego, CA USA
来源：
DIABETIC MEDICINE | 2015年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P122
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] THE EFFECT OF INSULIN DEGLUDEC IN COMBINATION WITH LIRAGLUTIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES REQUIRING TREATMENT INTENSIFICATION
    Aroda, V.
    Bailey, T.
    Cariou, B.
    Kumar, S.
    Leiter, L.
    Raskin, P.
    Zacho, J.
    Bandier, M.
    Philis-Tsimikas, A.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S261 - S262
  • [2] The effect of insulin degludec in combination with liraglutide and metformin in patients with type 2 diabetes requiring treatment intensification
    Aroda, V. R.
    Bailey, T.
    Cariou, B.
    Kumar, S.
    Leiter, L. A.
    Raskin, P.
    Zacho, J.
    Bandier, M.
    Philis-Tsimikas, A.
    [J]. DIABETOLOGIA, 2014, 57 : S68 - S68
  • [3] Real-world use of insulin degludec/liraglutide (IDegLira) significantly improves glycaemic control in patients with Type 2 diabetes
    Feher, M.
    Price, H.
    Schultes, B.
    Prager, R.
    Phan, T. M.
    Thorsted, B. L.
    Bluher, M.
    [J]. DIABETIC MEDICINE, 2018, 35 : 158 - 158
  • [4] Postprandial glycaemic control in patients with Type 2 diabetes on a combination of insulin degludec and liraglutide vs each component individually
    Gough, S. C. L.
    Rodbard, H. W.
    Woo, V. C.
    Linjawi, S.
    Poulsen, P.
    Damgaard, L. H.
    Bode, B. W.
    [J]. DIABETIC MEDICINE, 2014, 31 : 51 - 51
  • [5] Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes
    Gough, Stephen C. L.
    Jain, Rajeev
    Woo, Vincent C.
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (01) : 7 - 19
  • [6] Acarbose improves glycaemic control in patients with insulin - Treated type 2 diabetes.
    Simpson, H
    Robertson-Mackay, F
    Montegriffo, E
    Fox, C
    [J]. DIABETOLOGIA, 1999, 42 : A223 - A223
  • [7] One year treatment with exenatide improves β cell function and glycaemic control in metformin treated type 2 diabetes patients
    Bunck, M. C.
    Diamant, M.
    Corner, A.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Taskinen, M.-R.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    [J]. DIABETOLOGIA, 2007, 50 : S111 - S112
  • [8] Fixed Combination of Insulin Degludec and Liraglutide in Type 2 Diabetes Treatment
    Jaecke, E.
    Wilhelm, B.
    Kaiser, M.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (06): : 387 - 395
  • [9] Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes
    Sarah L. Greig
    Lesley J. Scott
    [J]. Drugs, 2015, 75 : 1523 - 1534
  • [10] Treatment intensification for patients with type 2 diabetes and poor glycaemic control
    Fu, A. Z.
    Sheehan, J. J.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (09): : 892 - 898
12345